Pharma Stocks
-
Infosys, TCS to LTIMindtree: IT stocks look cheap after up to 33% YTD fall, but upside may remain limited, say analysts
Indian IT stocks have remained under intense selling pressure over the past year amid global macroeconomic headwinds, muted earnings growth,…
Read More » -
Analysts Have Made A Financial Statement On Mankind Pharma Limited’s (NSE:MANKIND) Yearly Report
It’s been a good week for Mankind Pharma Limited (NSE:MANKIND) shareholders, because the company has just released its latest annual…
Read More » -
Do HELIOS Data Shift Amylyx (AMLX) From ALS Setback To Broader Rare-Disease Strategy Reboot?
Amylyx Pharmaceuticals recently reported that 24- and 48-week results from its Phase 2 open-label HELIOS trial of AMX0035 in adults…
Read More » -
CU6) Rises 9% as Traders Rotate Into Biotech Stocks
Shares of Clarity Pharmaceuticals Ltd. (ASX: CU6) climbed 9.33% on 21 May 2026 to A$2.76 per share, registering a notable…
Read More » -
oncology focus and pipeline updates draw investor attention
Astellas Pharma has been in focus following recent oncology pipeline updates and regulatory developments, keeping the Japanese drug maker on…
Read More » -
Cenexi recovery, new product launches and capacity additions power Gland Pharma outlook
Gland Pharma has gained 19% on the bourses in the past three trading sessions to hit a 52-week high after…
Read More » -
Assessing Indivior Pharmaceuticals (INDV) Valuation After Strong Long Term Share Price Momentum
Indivior Pharmaceuticals stock after recent performance Indivior Pharmaceuticals (INDV) has drawn fresh attention after recent share performance, with the stock…
Read More » -
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?
Shares of pharma companies rallied up to 7% on Wednesday as strong earnings, a weakening rupee, and other supportive factors…
Read More » -
FDA Approval Of Tessie Puts Orion’s Animal Health Potential In Focus
Orion Oyj (HLSE:ORNBV) has received FDA approval for its proprietary veterinary drug Tessie (tasipimidine) for use in the U.S. market.…
Read More » -
Chinese pharma player in focus after recent business u
Huadong Medicine Co Ltd has remained active with business and product updates, drawing attention to its role in China’s pharmaceutical…
Read More »